The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of care team-patient relationship on decision-making in relapsed/refractory multiple myeloma.
 
Cynthia Chmielewski
Consulting or Advisory Role - Bristol Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Kite, a Gilead company; Takeda
 
Patricia Alejandra Flores Pérez
No Relationships to Disclose
 
Jorge Arturo Hurtado Martínez
No Relationships to Disclose
 
Eduardo Franco Hernandez
No Relationships to Disclose
 
Karla Mariana Castro Bórquez
No Relationships to Disclose
 
Felipe Flores Quiroz
No Relationships to Disclose
 
Robert Z. Orlowski
Stock and Other Ownership Interests - Asylia Therapeutics, Inc.
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; AstraZeneca; BioTheryX; Bristol-Myers Squibb; GlaxoSmithKline; IASO Biotherapeutics; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Meridian Therapeutics; Monte Rosa Therapeutics; Neoleukin Therapeutics; Oncopeptides; Regeneron; Sanofi; Takeda
Research Funding - Asylia Therapeutics, Inc. (Inst); BioTheryX (Inst); CARsgen Therapeutics (Inst); Celgene/Bristol-Myers Squibb (Inst); Exelixis (Inst); Heidelberg Pharma (Inst); Janssen Biotech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Asylia Therapeutics, Inc.
 
Julie Strain
Employment - GlaxoSmithKline
 
Laura L. Iadeluca
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline; Pfizer
 
Virginie Delwart
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Rachel Solomon
Employment - Sanofi
 
Rachel M. Jensen
No Relationships to Disclose
 
Jennifer M. Ahlstrom
(OPTIONAL) Uncompensated Relationships - BioLineRx; Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Sanofi; Takeda
 
Jay R. Hydren
Research Funding - Adaptive Biotechnologies; GlaxoSmithKline; Johnson & Johnson; Pfizer; Regeneron; Sanofi
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb